WELL Health Technologies (TSX:WELL) 3-Year EBITDA Growth Rate : 0.00% (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is WELL Health Technologies 3-Year EBITDA Growth Rate?

WELL Health Technologies's EBITDA per Share for the three months ended in Sep. 2024 was C$-0.19.

During the past 12 months, WELL Health Technologies's average EBITDA Per Share Growth Rate was 97.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of WELL Health Technologies was 43.00% per year. The lowest was -75.40% per year. And the median was -12.65% per year.

Competitive Comparison of WELL Health Technologies's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, WELL Health Technologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WELL Health Technologies's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where WELL Health Technologies's 3-Year EBITDA Growth Rate falls into.

WELL Health Technologies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

WELL Health Technologies (TSX:WELL) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

WELL Health Technologies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of WELL Health Technologies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

WELL Health Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WELL Health Technologies Corp (TSX:WELL) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

WHTCF:USA W7V:Germany

Address

375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6

Website

https://www.well.company

WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.

Executives

Eva Fong	Senior Officer
Hamed Shahbazi	10% Security Holder, Director, Senior Officer
John Kim	Director
Amir Javidan	Senior Officer
Thomas Craig Liston	Director
Tara Mccarville	Director
Kenneth Anthony Cawkell	Director
Sybil E Jen Lau	Director
Well Health Technologies Corp.	Issuer
Arjun Kumar	Senior Officer
Brian Eric Levinkind	Director